首页> 外国专利> Derivatives of 4 - aryl - 2 (1H) quinazolinona and 4 - 2 - aryl - substituted quinazoline, a process for their preparation, Pharmaceutical compositions and the use of these derivatives for the preparation of a medicament

Derivatives of 4 - aryl - 2 (1H) quinazolinona and 4 - 2 - aryl - substituted quinazoline, a process for their preparation, Pharmaceutical compositions and the use of these derivatives for the preparation of a medicament

机译:4-芳基-2(1H)喹唑啉酮和4-2-芳基取代的喹唑啉的衍生物,其制备方法,药物组合物和这些衍生物在制备药物中的用途

摘要

The use of derivatives of 4-aril-2 (1H) - quinazolinona and 4-aril-quinazolina 2-alternative formula (1), wherein the remaining formula (2) is selected from the formula residue (3) or (4) of the original or the S; R1 represents the substitutes 1 to 3 independently selected from Oh, SH, halogen, NO2 (low tar, low oxygen), Low calcium, low calcium, low asphalt, low asphalt, low cathode, low cathode, low sulfur, low sulfur, low sulfur, or alternative; R2 is h or (low asphalt, arilo, arilalquilo, cyclopentadiene, cyclopentadienyl)Alternative alternatives: R3 represents one to three alternatives selected from the alternative halogen (low tar, low oxygen or ammonia); R4 'is cyanogen, halogen, nitrogen (- n = n = n),Alternative o (low tar, low oxygen, low thioxyl, ariloxilo, arilalcoxilo or amino), or an acceptable and separable ester or an acid salt for the preparation of drugs to promote the release of thyroid hormones, 1. Pharmaceutical ingredients containing these substances, using these derivatives to prepare drugs to promote the release of thyroid hormones, such as preventing or treating bone conditions related to the increasing depletion or dissolution of calcium;Or where bone formation and calcium fixation need to be stimulated. The preparation process of 4-aril-quinazolinonas derivatives was also introduced.
机译:使用4-芳基-2(1H)-喹唑啉酮和4-芳基-喹唑啉酮2-替代式(1)的衍生物,其中剩余的式(2)选自式(1)的残基(3)或(4)原件或S; R1代表1至3的取代基,分别选自Oh,SH,卤素,NO2(低焦油,低氧),低钙,低钙,低沥青,低沥青,低阴极,低阴极,低硫,低硫,低硫或替代品; R 2为h或(低沥青,芳基,芳基喹啉,环戊二烯,环戊二烯基)替代方案:R 3代表选自卤素的替代方案(低焦油,低氧或氨)中的一种至三种替代方案; R 4'是氰,卤素,氮(-n = n = n),替代的o(低焦油,低氧,低硫代基,阿立西洛,阿里洛西洛或氨基)或可接受的可分离的酯或酸盐,用于制备促进甲状腺激素释放的药物,1.含有这些物质的药物成分,使用这些衍生物制备促进甲状腺激素释放的药物,例如预防或治疗与钙的消耗或溶解增加有关的骨骼疾病;或需要刺激骨形成和钙固定。介绍了4-芳基-喹唑啉酮衍生物的制备方法。

著录项

  • 公开/公告号AR038658A1

    专利类型

  • 公开/公告日2005-01-26

    原文格式PDF

  • 申请/专利权人 NOVARTIS AG;

    申请/专利号AR2002P102233

  • 发明设计人

    申请日2002-06-13

  • 分类号A61K31/517;A61P5/18;A61P19/10;C07D239/82;C07D239/78;C07D239/83;C07D205/44;C07D417/08;C07D417/10;C07D401/12;C07D401/08;

  • 国家 AR

  • 入库时间 2022-08-21 22:18:51

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号